CN Stock MarketDetailed Quotes

Hangzhou Tianmushan Pharmaceutical Enterprise (600671)

Watchlist
  • 19.30
  • 0.000.00%
Noon Break May 20 11:29 CST
2.35BMarket Cap144.03P/E (TTM)

Hangzhou Tianmushan Pharmaceutical Enterprise (600671) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Drug circulation50.35M23.78%
Iron maple bucket40.13M18.95%
Other28.8M13.60%
Menthol brain26.34M12.44%
六味地黄口服液(无糖型)22.41M10.58%
参类12.7M6.00%
Cordyceps sinensis11.42M5.39%
酒系列8.41M3.97%
康源软胶囊6M2.83%
Training5.19M2.45%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Health products90.99M42.97%
流通商品50.35M23.78%
Raw material medicine30.3M14.31%
Chinese patent medicine28.26M13.35%
Service class5.19M2.45%
medical apparatus3.79M1.79%
Chemical drugs1.84M0.87%
Other979.71K0.46%
Other business57.55K0.03%
View all

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China region195.2M92.18%
South China5.96M2.81%
Southwest area5.38M2.54%
Central China3.17M1.50%
Northeast area894.56K0.42%
North China807.47K0.38%
Northwest region274.93K0.13%
Other business57.55K0.03%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More